Navigation Links
New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
Date:11/9/2010

oney/Waters Group212.886.2228, sfox@cooneywaters.comAbout Rheumatoid ArthritisRA affects more than 1.3 million Americans, and it is estimated that 5 million people suffer from RA globally.  Prevalence is not split evenly between genders, since women are three times more likely to be affected than men.  Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.

About REALISTIC StudyREALISTIC (RA Evaluation in Subjects Receiving TNF Inhibitor Certolizumab Pegol) is a multicenter phase IIIb trial in patients with active rheumatoid arthritis who have shown inadequate response to disease-modifying antirheumatic drugs, including patients with/without prior TNF-inhibitor exposure, with/without concomitant methotrexate or other disease-modifying anti-rheumatic drugs (DMARDs); and varying lengths of disease duration. The study demonstrated that – in a diverse group of RA patients reflecting those seen in daily clinical practice (including those with prior TNF- inhibitor use) – addition of CZP to current therapy was associated with a rapid clinical response consistent in all strata, improved function and reduced disease activity.

About Cimzia®Certolizumab pegol is the only PEGylated anti-TNF (Tumor Necrosis Factor).  It has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha.  Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation.  This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases.  The U.S. Food and Drug Administration (FDA) has approved certolizumab pegol for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult pati
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
2. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
3. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
4. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
5. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
6. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
7. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
9. Marken Rapidly Responds to Global Supply Chain Security Measures
10. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
11. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... than a third of reproductive-aged women enrolled in Medicaid, and ... a prescription for an opioid pain medication each year during ... Mortality Weekly Report (MMWR). Opioids are typically ... pain.  They are also found in some prescription cough medications. ...
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
(Date:1/23/2015)... Fla. , Jan. 23, 2015  HyGreen, Inc., a ... agreement and partnership with RCA Medical, a subsidiary of ... . Each year, hundreds of millions ... care-associated infections as organisms are transmitted from patient to ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... even minor orthopaedic trauma can lead to medical problems ... Feb. 25 Pregnant women who experience orthopaedic trauma ... prenatal complications if they receive care at a medical ... injuries, according to a study presented today at the ...
... New research offers hope, propels treatment for common orthopaedic ... and the Orthopaedic Research and Education Foundation (OREF) presented ... gap between basic research and clinical medicine, at the ... Orthopaedic Surgeons (AAOS) ( http://www.aaos.org/ ) . ...
Cached Medicine Technology:Orthopaedic Injury: High Risk to Pregnant Women 2Orthopaedic Injury: High Risk to Pregnant Women 3Applying Clinical Findings to the Practice of Medicine 2Applying Clinical Findings to the Practice of Medicine 3Applying Clinical Findings to the Practice of Medicine 4Applying Clinical Findings to the Practice of Medicine 5
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... 2015 Compare-autoinsurance.org has released a new blog post ... auto insurance policy . , Some types of vehicles ... check the newly released blog post to see if their vehicle ... damaged vehicles are some of the cars that cannot be covered ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Addition of intravenous magnesium sulfate to standard emergency ... rather than enhance the effectiveness of treatment.// Dr. ... College of Medicine in the Bronx, New York, ... be helpful in the treatment of migraine headache ...
... in animal products raises the risk of breast cancer, ... suggested a link between a high fat diet, rich ... based in Chicago, USA, reveals that dietary differences might ... high where the proportion of daily calories from animal ...
... killer, accounting for one in four deaths, more than ... that the diversity of lung disease has yet to ... deal only in one disorder, chest physicians look after ... asthma, pneumonia, cystic fibrosis and sleep apnoea. There are ...
... complications in ovarian cancer. A gene implicated in inherited ovarian ... Up to 10 per cent of cases of ovarian cancer ... these cases, the woman usually has a strong family history ... developing, although it's not yet known in detail how it ...
... year worldwide if more people at high risk of having ... An analysis of nearly 300 clinical trials of aspirin and ... that aspirin reduces heart attacks and strokes in susceptible patients. ... from aspirin and anti-platelet therapy receive it. ,“This ...
... at Hopkins University, they have found a way to use ... system, surpassing an obstacle to certain forms of gene ... body's immune response to developing cancer vaccines to reducing the ... core of the blood system.// They can give rise to ...
Cached Medicine News:Health News:A new study surpasses Gene Therapy Hurdle 2
Provides the security of suture and ease of automated knot tying for vascular closure of 5-8F....
... cardiac surgery patients require progressive solutions that ... return to everyday life. Since the ... have been able to provide nearly 400,000 ... care:, Faster ambulation , Shorter hospital ...
... CF-60DSi is an all-digital Fundus camera system that ... efficient workflow. The Canon CF-60DSi ... EOS-1Ds series SLR digital camera features a "full ... resolution and the new ICG unit, which features ...
... Intacs prescription inserts are an ophthalmologic medical ... of myopia from -1.00 to -3.00 diopters.* ... of the patient's central optical zone, the ... cornea. Intacs inserts is composed of two ...
Medicine Products: